NDC Package 0548-9090-10 Amphadase

Hyaluronidase Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0548-9090-10
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Amphadase
Non-Proprietary Name:
Hyaluronidase
Substance Name:
Hyaluronidase
Usage Information:
Amphadase® is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration.
11-Digit NDC Billing Format:
00548909010
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 238271 - hyaluronidase, bovine 150 UNT in 1 ML Injection
  • RxCUI: 238271 - 1 ML hyaluronidase, bovine 150 UNT/ML Injection
  • RxCUI: 238271 - hyaluronidase, bovine 150 UNT per 1 ML Injection
  • RxCUI: 542925 - AMPHADASE 150 UNT in 1 ML Injection
  • RxCUI: 542925 - 1 ML hyaluronidase, bovine 150 UNT/ML Injection [Amphadase]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amphastar Pharmaceuticals, Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA021665
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-26-2004
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0548-9090-10?

    The NDC Packaged Code 0548-9090-10 is assigned to a package of 10 vial, single-dose in 1 carton / 1 ml in 1 vial, single-dose of Amphadase, a human prescription drug labeled by Amphastar Pharmaceuticals, Inc.. The product's dosage form is injection and is administered via subcutaneous form.

    Is NDC 0548-9090 included in the NDC Directory?

    Yes, Amphadase with product code 0548-9090 is active and included in the NDC Directory. The product was first marketed by Amphastar Pharmaceuticals, Inc. on October 26, 2004 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0548-9090-10?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0548-9090-10?

    The 11-digit format is 00548909010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20548-9090-105-4-200548-9090-10